Your browser doesn't support javascript.
loading
Corrigendum to ''Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type'' [EBioMedicine 51 (2020) 102526].
Cai, Qi; Christie, Alana; Rajaram, Satwik; Zhou, Qinbo; Araj, Ellen; Chintalapati, Suneetha; Singla, Nirmish; Cadeddu, Jeffrey; Margulis, Vitaly; Pedrosa, Ivan; Rakheja, Dinesh; McKay, Renee M; Brugarolas, James; Kapur, Payal.
Afiliación
  • Cai Q; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Christie A; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Rajaram S; Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Zhou Q; Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Araj E; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Chintalapati S; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Singla N; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Cadeddu J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Margulis V; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Institute for Urology and Reproductive Health, Sechen
  • Pedrosa I; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwes
  • Rakheja D; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • McKay RM; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States.
  • Brugarolas J; Department of Internal Medicine, Hematology-Oncology Division, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States. Electronic ad
  • Kapur P; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States; Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwes
EBioMedicine ; 55: 102707, 2020 05.
Article en En | MEDLINE | ID: mdl-32339934
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: EBioMedicine Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos